ABSTRACT

Conventional surgical and minimally invasive treatment methods aimed to decrease complications have been used in the management of obstruction due to Benign Prostatic Hyperplasia. Conventional methods include transurethral resection of the prostate (TURP), open prostatectomy, transurethral incision and transurethral vaporization of the prostate. Treatments with thermal effect including lasers, and stents are so called minimally invasive therapies. TURP is still the gold standard of treatment. Minimally invasive treatments have lower intraoperative complications than TURP while attaining comparable early postoperative results. However, they appear less successful than TURP with regard to long-term outcomes. One of the outstanding differences in the long term is in the re-operation rates. Re-operation rates after minimally invasive interventions bring the higher burden of both morbidity and cost. It seems that rapid developments in laser methods shrink the differences between the reoperation rates after these two treatment modalities.